Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 931 | 2021 |
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 299 | 2021 |
Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco … A Contejean, V Lemiale, M Resche-Rigon, D Mokart, F Pène, A Kouatchet, ... Annals of intensive care 6, 1-9, 2016 | 78 | 2016 |
Clinical significance of upper airway virus detection in critically ill hematology patients J Legoff, N Zucman, V Lemiale, D Mokart, F Pène, J Lambert, A Kouatchet, ... American journal of respiratory and critical care medicine 199 (4), 518-528, 2019 | 56 | 2019 |
Epidemiology, clinical picture and long‐term outcomes of FIP1L1‐PDGFRA‐positive myeloid neoplasm with eosinophilia: Data from 151 patients J Rohmer, A Couteau‐Chardon, J Trichereau, K Panel, C Gesquiere, ... American Journal of Hematology 95 (11), 1314-1323, 2020 | 54 | 2020 |
Comparing dynamics and determinants of SARS-CoV-2 transmissions among health care workers of adult and pediatric settings in central Paris A Contejean, J Leporrier, E Canouï, F Alby-Laurent, E Lafont, L Beaudeau, ... medRxiv, 2020.05. 19.20106427, 2020 | 53* | 2020 |
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 43 | 2022 |
Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients M Lamarque, C Bossard, A Contejean, P Brice, M Parrens, S Le Gouill, ... Haematologica 101 (3), e103, 2016 | 43 | 2016 |
Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia A Contejean, M Resche-Rigon, J Tamburini, M Alcantara, F Jardin, ... Blood 132 (Supplement 1), 1298-1298, 2018 | 34 | 2018 |
Association study between herpes zoster reporting and mRNA COVID‐19 vaccines (BNT162b2 and mRNA‐1273) LH Préta, A Contejean, F Salvo, JM Treluyer, C Charlier, L Chouchana British Journal of Clinical Pharmacology 88 (7), 3529-3534, 2022 | 32 | 2022 |
Antimicrobial stewardship in high-risk febrile neutropenia patients A Contejean, S Abbara, R Chentouh, S Alviset, E Grignano, N Gastli, ... Antimicrobial Resistance & Infection Control 11 (1), 52, 2022 | 30 | 2022 |
Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia J Zerbit, J Tamburini, L Goldwirt, J Decroocq, JM Cayuela, N Chapuis, ... Leukemia & Lymphoma 62 (14), 3558-3560, 2021 | 23 | 2021 |
Nationwide survey in France on the use of romiplostim in patients with refractory severe aplastic anemia LP Zhao, F Sicre De Fontbrune, A Contejean, J Abraham, L Terriou, ... Bone Marrow Transplantation 54 (7), 1161-1163, 2019 | 22 | 2019 |
Usefulness of plasma SARS-CoV-2 RNA quantification by droplet-based digital PCR to monitor treatment against COVID-19 in a B-cell lymphoma patient TA Szwebel, D Veyer, N Robillard, D Eshagh, E Canoui, T Bruneau, ... Stem Cell Reviews and Reports 17, 296-299, 2021 | 20 | 2021 |
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing … A Maillard, T Delory, J Bernier, A Villa, K Chaibi, L Escaut, A Contejean, ... International Journal of Antimicrobial Agents 62 (1), 106809, 2023 | 18 | 2023 |
Combination of vancomycin plus piperacillin and risk of acute kidney injury: a worldwide pharmacovigilance database analysis A Contejean, M Tisseyre, E Canouï, JM Treluyer, S Kerneis, L Chouchana Journal of Antimicrobial Chemotherapy 76 (5), 1311-1314, 2021 | 17 | 2021 |
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis R Vazquez, C Breal, L Zalmai, C Friedrich, C Almire, A Contejean, ... Blood Cancer Journal 11 (3), 62, 2021 | 15 | 2021 |
Assessing the risk of adverse pregnancy outcomes and birth defects reporting in women exposed to ganciclovir or valganciclovir during pregnancy: a pharmacovigilance study A Contejean, M Leruez-Ville, JM Treluyer, V Tsatsaris, Y Ville, C Charlier, ... Journal of Antimicrobial Chemotherapy 78 (5), 1265-1269, 2023 | 12 | 2023 |
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: findings from an economic, clinical and organisational analysis J Zerbit, M Kroemer, B Fuchs, M Detroit, J Decroocq, M Vignon, L Willems, ... European Journal of Cancer Care 31 (6), e13753, 2022 | 9 | 2022 |
Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infections E Canouï, S Kerneis, P Morand, M Enser, R Gauzit, L Eyrolle, P Leclerc, ... Journal of Antimicrobial Chemotherapy 77 (5), 1344-1352, 2022 | 9 | 2022 |